
1. Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211050764. doi:
10.1177/15330338211050764.

Challenges in Advanced Lung Cancer Diagnosis During the COVID-19 Pandemic.

Xu C(1)(2)(3), Li L(1)(2)(3), Wang W(1)(2)(3).

Author information: 
(1)206608Nanjing Chest Hospital, Nanjing, China.
(2)Affiliated Nanjing Brain Hospital, 56647Nanjing Medical University, Nanjing,
China.
(3)Clinical Center of Nanjing Respiratory Diseases and Imaging, Nanjing, China.

A pandemic of coronavirus diseases 2019 (COVID-19) outbreak is a major public
health emergency that has spread in the fastest speed, and caused the most
extensive infection world widely. Transbronchial biopsy (TBB) and computed
tomography guided percutaneous needle biopsy (CTPNB) is the most common and
significant method for the diagnosis of lung cancer. During the COVID-19
pandemic, the indications of TBB and CTPNB must be managed strictly. Therefore,
it is extremely indispensable to perform meticulous and individualized management
for lung cancer patients to protect the patients from COVID-19.

DOI: 10.1177/15330338211050764 
PMCID: PMC8524682
PMID: 34657503  [Indexed for MEDLINE]

